214 related articles for article (PubMed ID: 32927671)
1. A Modern Approach to Endometrial Carcinoma: Will Molecular Classification Improve Precision Medicine in the Future?
Marnitz S; Walter T; Schömig-Markiefka B; Engler T; Kommoss S; Brucker SY
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32927671
[TBL] [Abstract][Full Text] [Related]
2. Molecular classification of endometrial carcinoma, is it the new era of precision medicine?
Bidzinski M; Danska-Bidzinska A; Rychlik A; Kypryjanczyk J; Pyzlak M; Piatek S
Ginekol Pol; 2022; 93(2):163-167. PubMed ID: 35072255
[TBL] [Abstract][Full Text] [Related]
3. New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines.
Santoro A; Angelico G; Travaglino A; Inzani F; Arciuolo D; Valente M; D'Alessandris N; Scaglione G; Fiorentino V; Raffone A; Zannoni GF
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073635
[TBL] [Abstract][Full Text] [Related]
4. Reclassifying endometrial carcinomas with a combined morphological and molecular approach.
Carlson J; McCluggage WG
Curr Opin Oncol; 2019 Sep; 31(5):411-419. PubMed ID: 31261170
[TBL] [Abstract][Full Text] [Related]
5. Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice.
de Biase D; Maloberti T; Corradini AG; Rosini F; Grillini M; Ruscelli M; Coluccelli S; Altimari A; Gruppioni E; Sanza V; Turchetti D; Galuppi A; Ferioli M; Giunchi S; Dondi G; Tesei M; Ravegnini G; Abbati F; Rubino D; Zamagni C; De Iaco P; Santini D; Ceccarelli C; Perrone AM; Tallini G; De Leo A
Front Med (Lausanne); 2023; 10():1146499. PubMed ID: 37064027
[TBL] [Abstract][Full Text] [Related]
6.
De Leo A; de Biase D; Lenzi J; Barbero G; Turchetti D; Grillini M; Ravegnini G; Angelini S; Zamagni C; Coluccelli S; Dondi G; De Iaco P; Perrone AM; Tallini G; Santini D; Ceccarelli C
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33668727
[TBL] [Abstract][Full Text] [Related]
7. Classification of Endometrial Carcinoma: New Perspectives Beyond Morphology.
Akhtar M; Al Hyassat S; Elaiwy O; Rashid S; Al-Nabet ADMH
Adv Anat Pathol; 2019 Nov; 26(6):421-427. PubMed ID: 31567131
[TBL] [Abstract][Full Text] [Related]
8. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
McAlpine J; Leon-Castillo A; Bosse T
J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
[TBL] [Abstract][Full Text] [Related]
9. Molecular classification of endometrial carcinoma: a clinically oriented review.
Loukovaara M; Pasanen A; Bützow R
J Clin Pathol; 2022 May; ():. PubMed ID: 35636924
[TBL] [Abstract][Full Text] [Related]
10. The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions.
Alexa M; Hasenburg A; Battista MJ
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33806979
[TBL] [Abstract][Full Text] [Related]
11. A clinically applicable molecular-based classification for endometrial cancers.
Talhouk A; McConechy MK; Leung S; Li-Chang HH; Kwon JS; Melnyk N; Yang W; Senz J; Boyd N; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
Br J Cancer; 2015 Jul; 113(2):299-310. PubMed ID: 26172027
[TBL] [Abstract][Full Text] [Related]
12. Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.
Hoang LN; Kinloch MA; Leo JM; Grondin K; Lee CH; Ewanowich C; Köbel M; Cheng A; Talhouk A; McConechy M; Huntsman DG; McAlpine JN; Soslow RA; Gilks CB
Am J Surg Pathol; 2017 Feb; 41(2):245-252. PubMed ID: 28079598
[TBL] [Abstract][Full Text] [Related]
13. Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification.
Kasius JC; Pijnenborg JMA; Lindemann K; Forsse D; van Zwol J; Kristensen GB; Krakstad C; Werner HMJ; Amant F
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34831000
[TBL] [Abstract][Full Text] [Related]
14. New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care.
Talhouk A; McAlpine JN
Gynecol Oncol Res Pract; 2016; 3():14. PubMed ID: 27999680
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of endometrial cancer and therapeutic implications.
Chang Z; Talukdar S; Mullany SA; Winterhoff B
Curr Opin Obstet Gynecol; 2019 Feb; 31(1):24-30. PubMed ID: 30507624
[TBL] [Abstract][Full Text] [Related]
16. The genetic landscape of endometrial clear cell carcinomas.
DeLair DF; Burke KA; Selenica P; Lim RS; Scott SN; Middha S; Mohanty AS; Cheng DT; Berger MF; Soslow RA; Weigelt B
J Pathol; 2017 Oct; 243(2):230-241. PubMed ID: 28718916
[TBL] [Abstract][Full Text] [Related]
17. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Talhouk A; McConechy MK; Leung S; Yang W; Lum A; Senz J; Boyd N; Pike J; Anglesio M; Kwon JS; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
Cancer; 2017 Mar; 123(5):802-813. PubMed ID: 28061006
[TBL] [Abstract][Full Text] [Related]
18. Molecular Genetics of Endometrial Carcinoma.
Bell DW; Ellenson LH
Annu Rev Pathol; 2019 Jan; 14():339-367. PubMed ID: 30332563
[TBL] [Abstract][Full Text] [Related]
19. The role of TCGA molecular classification in clear cell endometrial carcinoma.
Tang X; Hu Y
Front Oncol; 2023; 13():1147394. PubMed ID: 37456263
[TBL] [Abstract][Full Text] [Related]
20. Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?
Gargiulo P; Della Pepa C; Berardi S; Califano D; Scala S; Buonaguro L; Ciliberto G; Brauchli P; Pignata S
Cancer Treat Rev; 2016 Jul; 48():61-8. PubMed ID: 27362548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]